Literature DB >> 22543768

The ureter as a landmark for robotic sacrocolpopexy.

Mona McCullough1, Jessica Valceus, Katheryne Downes, Lennox Hoyte.   

Abstract

OBJECTIVE: The objective of this study was to report on the location of the ureters in relation to the sacral promontory at the level of the pelvic brim.
METHODS: Female patients undergoing indicated computed tomographic (CT) urograms were selected for this study. Charts and images from a defined 3-year study period were reviewed. The GE Centricity software was used to evaluate multiplanar CT views and measure the distance from the bilateral ureters to the midpoint of the distal sacral promontory for each subject.
RESULTS: Sixty-three women underwent CT urography during the study period. Of these, 38 met the criteria for inclusion. Among these, the left ureter was 35.9 ± 4.9 mm lateral to the midsacral promontory. The right ureter was 29.7 ± 6.2 mm lateral to the sacral promontory.
CONCLUSIONS: On average, the sacral promontory is located 29.7 mm medial to the right ureter at the level of the pelvic brim. This represents a landmark that may prove clinically useful, along with other visual cues, in choosing the proper location for careful dissection toward the anterior longitudinal ligament during robotic sacrocolpopexy.

Entities:  

Mesh:

Year:  2012        PMID: 22543768     DOI: 10.1097/SPV.0b013e3182544e17

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  2 in total

Review 1.  Minimally Invasive Sacrocolpopexy: How to Avoid Short- and Long-Term Complications.

Authors:  Catherine A Matthews
Journal:  Curr Urol Rep       Date:  2016-11       Impact factor: 3.092

2.  Characterization of the median sacral artery course at the sacral promontory using contrast-enhanced computed tomography.

Authors:  Ariel Zilberlicht; Ron Molnar; Hanni Pal-Ohana; Nir Haya; Ron Auslender; Yoram Abramov
Journal:  Int Urogynecol J       Date:  2016-07-02       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.